Publications
569
Citations
10,805
Est. group size
~33
Recurring co-author estimate
Active years
28
Publishing since 1999
Typically publishes in teams of ~19 · 1% small-team papers (≤3 authors) · across 34 venues
- Non-invasive prostate cancer subtyping using 5hmC-sequencing of cell-free DNA.
Journal of Clinical Oncology · 2026
- Epigenomic alterations associated with androgen receptor pathway inhibitor response in metastatic castration-resistant prostate cancer.
Journal of Clinical Oncology · 2026
- Physician perspectives on the implementability of a cardiovascular risk score for prostate cancer: A PRISM-guided evaluation.
Journal of Clinical Oncology · 2026
- Restoration of Immune Surveillance in Prostate Cancer Prevention by Sulforaphane in Hi‐Myc Mice
Molecular Carcinogenesis · 2026
- Abstract 5929: Global mRNA 3’UTR lengthening in small-cell neuroendocrine carcinoma
Cancer Research · 2026
- Abstract 1294: Deciphering single-cell heterogeneity and cellular ecosystem dynamics during prostate cancer progression.
Cancer Research · 2026
- Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Genome biology · 2026
- Additional file 1 of Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Figshare · 2026
- Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Figshare · 2026
- Additional file 2 of Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Figshare · 2026
- Additional file 1 of Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Figshare · 2026
- Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Figshare · 2026
- Additional file 2 of Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer
Figshare · 2026
- Supplementary Figure S19 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types
2026
- Supplementary Figure S2 from Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer Types
2026
- Journal of Clinical Oncology×41
- Cancer Research×17
- Clinical Cancer Research×7
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Figshare×6
- Phoebe A. Tsao
Medicine · University of Michigan
- Martin Gleave
Medicine · University of Michigan
- Charles J. Ryan
Medicine · University of Michigan
- Arul M. Chinnaiyan
Medicine · University of Michigan
- Jennifer A. Sinnott
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile